We also found reduced ORP3 expression throughout tumor progression in the N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN)-induced mouse BC model (Fig. 4F, G and Supplementary Fig. 3). This evidence concerns the gene OSBPL3 and breast cancer.